CRB Bio II fully exited its position in genomics diagnostics company Health in Code, first backed in 2013, realizing roughly a 3x return multiple.
Health in Code specializes in genomic data management and personalized medicine, focusing on providing genetic testing and analysis for healthcare professionals to improve clinical decision-making and patient outcomes
Health in Code specializes in genomic data management and personalized medicine, focusing on providing genetic testing and analysis for healthcare professionals to improve clinical decision-making and patient outcomes.